Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP961778priorityCriticalpatent/ECSP961778A/en
Publication of ECSP961778ApublicationCriticalpatent/ECSP961778A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
El invento se refiere a composiciones que incrementan la biodisponibilidad de inhibidores de proteinasa. La composición incluye un portador farmacéuticamente aceptable que comprnede monoglicéridos de ácidos grasos de cadena media.The invention relates to compositions that increase the bioavailability of proteinase inhibitors. The composition includes a pharmaceutically acceptable carrier that comprises medium chain fatty acid monoglycerides.
ECSP9617781996-06-061996-06-06
COMPOSITIONS THAT INCREASE THE BIOAVAILABILITY OF PROTEINASE INHIBITORS
ECSP961778A
(en)
Arylpyridazinone-derivatives having prostaglandin endoperoxide h synthase biosynthesis inhibitor effect and pharmaceutical compositions containing them